Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05996575 · ClinicalTrials.gov registry record
Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS
A clinical trial, sponsored by Kernel.
- Completed
- Registry status
- 133
- Enrollment target
NCT05996575: Completed study, sponsored by Kernel.
NCT05996575 is a clinical trial that has completed, run by Kernel. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05996575 has completed, sponsored by Kernel.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
The goal of the proposed observational, multi-site study is to use fNIRS neurophysiological data recorded during a battery of tasks to detect MCI within a cohort consisting of patients and age-matched healthy controls. Furthermore, the investigators aim to explore whether they can measure the severity of MCI symptoms in the patient population. If successful, this approach enables clinicians to track the disease at its source-the brain; possibly allowing for earlier detection of MCI and its progression, and ultimately more efficient interventions.
Primary Outcome
This includes changes in the concentration of oxygenated and deoxygenated hemoglobin as measured by the change in light absorption.
Interventions
- OTHER fNIRS measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2024-06-13 |
What the finished NCT05996575 record still lists
NCT05996575 is an observational study that tracks outcomes without assigning an intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which fNIRS measurement is the first listed.
NCT05996575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05996575 about?
NCT05996575 is a clinical study titled "Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS". The goal of the proposed observational, multi-site study is to use fNIRS neurophysiological data recorded during a battery of tasks to detect MCI within a cohort consisting of patients and age-matched healthy controls. Furthermore, the investigators aim to explore whether they can measure the severi...
What is the current status of trial NCT05996575?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2023-07-25. Estimated completion is 2024-06-13.
What interventions are being tested in trial NCT05996575?
The interventions under investigation include: fNIRS measurement (OTHER).
Who is sponsoring clinical trial NCT05996575?
This trial is sponsored by Kernel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI